Examining Real World Evidence in the Management of Breast Cancer: Pharmacist Implications (Dec 07, 2018 - Dec 07, 2019)

Examining Real World Evidence in the Management of Breast Cancer: Pharmacist Implications is organized by Power-Pak C.E. - Continuing Education for Pharmacists & Pharmacy Technicians and will be held from Dec 07, 2018 - Dec 07, 2019.

Credits: 1.0 hours (0.10 ceu)

Target Audience:
This accredited activity has been designed for oncology, health system, managed care and specialty pharmacists.

Goal:
To inform oncology, health-system, managed care and specialty pharmacists, as well as other pharmacists who interact with BC patients, on (1) real world evidence (RWE) and how it may be used to support approval of new drugs or indications (2) approaches to interpreting and analyzing study design and results of real world data (RWD) for possible inclusion in treatment decision making; (3) RWE of CDK 4/6 inhibitors in breast cancer for the development of treatment regimens based on patient specific factors thus leading to improved outcomes.

Educational Objectives:
At the conclusion of this activity, the learner will be better able to:
• Recognize real world evidence (RWE) and how it may be used to support approval of new drugs or indications.
• Identify approaches to interpreting and analyzing study design and results of real world data (RWD) for possible inclusion in treatment decision making.
• Translate RWE of CDK 4/6 inhibitors in breast cancer for the development of treatment regimens based on patient specific factors.

Additional details will be posted as soon as they are available.